Document
Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Patient Focus Groups 2020
ICR 201712-0910-001 · OMB 0910-0695 · Object 100125301.
This document may belong to an older filing. More recent activity for OMB 0910-0695:
Document Viewer [docx]
Document Metadata
| File Type | application/octet-stream |
|---|---|
| File Title | Studies to Enhance FDA Communications Addressing Biosimilar Drug Products: Patient Focus Groups 2020 |
| Author | Rupert, Douglas |
| Last Modified By | Writer |
| File Modified | 2020-04-03 |
| File Created | 2026-09-24 |
| Conversion State | complete |